Novartis Investigative Site

Encinitas, California 92024-1332

0 studies enrolling now · 8 studies all time

What they study most

Asthma, COPD, Chronic Obstructive Pulmonary Disease, Non Familial Chylocmicronemia Syndrome (Non-FCS), Persistent Asthma, Plaque Psoriasis

Studies at this site

• Dose Finding Study for QAW039 in Asthma — Completed
• Efficacy, Safety, and Pharmacokinetics of QAW039 — Completed
• A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia — Completed
• Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment — Stopped early
• Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis — Completed
• A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients — Completed
• Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed